Department of Biomaterials, Radboud University Medical Center, 6500 HB Nijmegen, the Netherlands.
Department of Pharmacy, University of Copenhagen, Universitetsparken 2, DK-2100 Copenhagen, Denmark; Wuya College of Innovation, Shenyang Pharmaceutical University, Wenhua Road No. 103, 110016 Shenyang, China.
Int J Pharm. 2019 Jun 10;564:1-9. doi: 10.1016/j.ijpharm.2019.04.023. Epub 2019 Apr 9.
The aim of this study was to investigate the influence of end group of poly(lactic-co-glycolic acid) (PLGA) on the drug loading and release behavior of electrospray-generated PLGA microspheres. To this end, doxycycline hyclate (DOX) was selected as a model drug, and PLGA (molecular weight: 17 and 44 kDa) with either an acid or ester end group were electrosprayed with DOX. The processing parameters were optimized to obtain microspheres comparable in size. Drug loading efficiency and release profile were determined by the high-performance liquid chromatography-ultraviolet detection (HPLC-UV) method. PLGA polymers or drug-loaded microspheres were characterized before and after exposure to phosphate buffer saline at 37 °C regarding the wettability of polymers, pH changes of the buffer, molecular weight of PLGA and morphology of the microspheres. The acid end group of PLGA microspheres brought about lower encapsulation efficiency and faster DOX release rate in our study, indicating that different hydrophilicity of polymer and degradation speed were the main reasons causing a difference in encapsulation efficiency and release profile. In addition, DOX released from the PLGA microspheres was active by showing antibacterial effects against Porphyromonas gingivalis as measured using a zone of inhibition test, and varying the end groups showed no impact on the antibacterial efficacy. This study demonstrated that the end group of PLGA can be used as a new tool to regulate drug encapsulation efficiency and release rate to meet different clinical drug delivery requirements.
本研究旨在探讨聚乳酸-共-乙醇酸(PLGA)的端基对电纺 PLGA 微球载药和释放行为的影响。为此,选择盐酸多西环素(DOX)作为模型药物,采用酸端基和酯端基的 PLGA(分子量:17 和 44 kDa)与 DOX 进行电纺。优化加工参数以获得具有可比粒径的微球。通过高效液相色谱-紫外检测(HPLC-UV)法测定载药效率和释放曲线。在 37°C 的磷酸盐缓冲液中对 PLGA 聚合物或载药微球进行暴露前后的特性研究,包括聚合物的润湿性、缓冲液 pH 值变化、PLGA 的分子量和微球的形态。在我们的研究中,PLGA 微球的酸端基导致包封效率降低和 DOX 释放速度加快,表明聚合物的不同亲水性和降解速度是导致包封效率和释放曲线差异的主要原因。此外,通过抑菌圈试验测定,从 PLGA 微球中释放的 DOX 具有活性,对牙龈卟啉单胞菌表现出抗菌作用,而改变端基对其抗菌效果没有影响。本研究表明,PLGA 的端基可用作一种新工具,调节药物包封效率和释放率,以满足不同临床药物输送的要求。